Uehling D T, Hussey J L, Weinstein A B, Wank R, Bach F H
Surgery. 1976 Mar;79(3):278-82.
Five recipients of successful living related donor kidney transplants stopped azathioprine and prednisone against medical advice. Two recipients who were nonidentical by human leukocyte (HL-A) serotyping and mixed leukocyte culture (MLC) became uremic again after cessation if immunosuppression for periods of 2 and 6 months. Both patients died while refusing to reinstitute iunosuppression and their kidneys showed severe rejection histologically. Three recipients of MCL and HL-A identical kidneys were off azathioprine and prednisone for periods of 7, 12, and 30 months, respectively. None developed changes in renal function. Two patients currently are back on immunosuppression. The third recipient remains stable although off immunosuppression for 36 months; her cessation of immunosuppression was elicited by a mailed questionnaire sent to all recipients following detection of the first four. In addition to these five patients, three recipients of cadaver kidneys lost graft function after lapses in immunosuppression. This represents a 4% incidence of major lapses in immunosuppression (excluding known cessation during sepsis). The clinical outcome depended on degree of histocompatibility as best measured by MLC.
五名接受成功的亲属活体供肾移植的受者不听从医嘱停用了硫唑嘌呤和泼尼松。两名通过人类白细胞(HL-A)血清分型和混合淋巴细胞培养(MLC)显示不匹配的受者,在停用免疫抑制药物2个月和6个月后再次出现尿毒症。两名患者均在拒绝重新进行免疫抑制治疗时死亡,其肾脏在组织学上显示出严重排斥反应。三名MLC和HL-A匹配的肾脏受者分别停用硫唑嘌呤和泼尼松7个月、12个月和30个月。肾功能均未出现变化。两名患者目前重新开始免疫抑制治疗。第三名受者尽管已停用免疫抑制药物36个月,但仍保持稳定;在发现前四名受者停药后,通过向所有受者发送邮寄问卷促使她停用免疫抑制药物。除了这五名患者外,三名尸体肾受者在免疫抑制治疗中断后失去了移植肾功能。这代表免疫抑制治疗严重中断的发生率为4%(不包括已知的败血症期间停药情况)。临床结果取决于通过MLC衡量的组织相容性程度。